1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Pharmaceutical Intermediates Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Pharmaceutical Intermediates Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Pharmaceutical Intermediates Market Regional Analysis
6.2 Middle East and Africa Pharmaceutical Intermediates Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Pharmaceutical Intermediates Market Forecast Analysis
7. Middle East and Africa Pharmaceutical Intermediates Market Analysis – by Type
7.1 GMP
- 7.1.1 Overview
- 7.1.2 GMP: Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Non GMP
- 7.2.1 Overview
- 7.2.2 Non GMP: Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East and Africa Pharmaceutical Intermediates Market Analysis – by Application
8.1 Antibiotics
- 8.1.1 Overview
- 8.1.2 Antibiotics: Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Antipyretic Analgesics
- 8.2.1 Overview
- 8.2.2 Antipyretic Analgesics: Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Vitamins
- 8.3.1 Overview
- 8.3.2 Vitamins: Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East and Africa Pharmaceutical Intermediates Market Analysis – by Distribution Channel
9.1 Distributor
- 9.1.1 Overview
- 9.1.2 Distributor: Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Direct Sales
- 9.2.1 Overview
- 9.2.2 Direct Sales : Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Middle East and Africa Pharmaceutical Intermediates Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Middle East and Africa Pharmaceutical Intermediates Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.1.2 South Africa: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.1.3 South Africa: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
- 10.2.1.2 Saudi Arabia:
Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
- 10.2.1.3 UAE:
Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 UAE: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.3.2 UAE: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.3.3 UAE: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
- 10.2.1.4 Rest of Middle East and Africa:
Middle East and Africa Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Application
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Pharmaceutical Intermediates Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 BASF SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 chiracon GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Codexis
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Dishman Carbogen Amcis Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Midas Pharma GmbH
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Pfizer Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Sanofi
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Middle East and Africa Pharmaceutical Intermediates Market
